 | • レポートコード：D0804-11478 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、152ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ロピバカインの世界市場を広く調査・分析し、今後の市場展望をまとめております。ロピバカインの種類別市場規模（腰部硬膜外投与、胸部硬膜外投与、地域ブロック）、用途別市場規模（麻酔、全身性神経障害性疼痛、帯状疱疹後疼痛、手術後疼痛、外科的鎮痛、分娩鎮痛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、PainReform Ltd、Taiwan Liposome Company、Aspen Pharmacare、Encore Therapeutics、Celgene、Yichang Renfu Pharmaceutical、Heron Therapeutics、Nuvo Pharmaceuticals、Anhui Wellman Pharmaceutical、Chengdu Tiantaishan Pharmaceutical、Jiangsu Enhua Pharmaceutical、Shandong New Era Pharmaceutical、Zhejiang Xianju Pharmaceutical、Yangtze Pharmaceutical Group、Guangdong Jiabo Pharmaceutical、Shanxi Pude Pharmaceutical、Hebei Yipin Pharmaceutical、Jiangsu Hengrui Pharmaceutical、Guangdong Huarun Shunfeng Pharmaceutical、Hainan Sida Pharmaceutical、Shenyang Sansheng Pharmaceutical、Qilu Pharmaceutical、Shaanxi Bosen Biopharmaceutical、Xi'an Hanfeng Pharmaceutical、Chenxin Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・ロピバカインの北米市場（アメリカ、カナダ、メキシコ） ・ロピバカインのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ロピバカインのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ロピバカインの南米市場（ブラジル、アルゼンチン） ・ロピバカインの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腰部硬膜外投与、胸部硬膜外投与、地域ブロック ・用途別分析：麻酔、全身性神経障害性疼痛、帯状疱疹後疼痛、手術後疼痛、外科的鎮痛、分娩鎮痛、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Ropivacaine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ropivacaine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
This report also the impact of Covid-19 outbreak on the Ropivacaine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Ropivacaine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Ropivacaine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ropivacaine market has been segmented into
Lumbar Epidural Administration
Thoracic Epidural Administration
Regional Block
By Application, Ropivacaine has been segmented into:
Anesthesia
Systemic Neuropathic Pain
Postherpes Pain
Post-Operative Pain
Surgical Analgesia
Labor Analgesia
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ropivacaine market presented in the report. This section sheds light on the sales growth of different regional and country-level Ropivacaine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ropivacaine market.
The report offers in-depth assessment of the growth and other aspects of the Ropivacaine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ropivacaine Market Share Analysis
Ropivacaine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ropivacaine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ropivacaine sales, revenue and market share for each player covered in this report.
The major players covered in Ropivacaine are:
AstraZeneca
PainReform Ltd
Taiwan Liposome Company
Aspen Pharmacare
Encore Therapeutics
Celgene
Yichang Renfu Pharmaceutical
Heron Therapeutics
Nuvo Pharmaceuticals
Anhui Wellman Pharmaceutical
Chengdu Tiantaishan Pharmaceutical
Jiangsu Enhua Pharmaceutical
Shandong New Era Pharmaceutical
Zhejiang Xianju Pharmaceutical
Yangtze Pharmaceutical Group
Guangdong Jiabo Pharmaceutical
Shanxi Pude Pharmaceutical
Hebei Yipin Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Guangdong Huarun Shunfeng Pharmaceutical
Hainan Sida Pharmaceutical
Shenyang Sansheng Pharmaceutical
Qilu Pharmaceutical
Shaanxi Bosen Biopharmaceutical
Xi’an Hanfeng Pharmaceutical
Chenxin Pharmaceutical
Among other players domestic and global, Ropivacaine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ropivacaine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ropivacaine, with price, sales, revenue and global market share of Ropivacaine in 2018 and 2019.
Chapter 3, the Ropivacaine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ropivacaine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ropivacaine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ropivacaine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ropivacaine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ropivacaine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Lumbar Epidural Administration
1.2.3 Thoracic Epidural Administration
1.2.4 Regional Block
1.3 Market Analysis by Application
1.3.1 Overview: Global Ropivacaine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Anesthesia
1.3.3 Systemic Neuropathic Pain
1.3.4 Postherpes Pain
1.3.5 Post-Operative Pain
1.3.6 Surgical Analgesia
1.3.7 Labor Analgesia
1.3.8 Other
1.4 Overview of Global Ropivacaine Market
1.4.1 Global Ropivacaine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Ropivacaine Industry Impact
1.6.1 COVID-19 Potential Implications for the Ropivacaine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Ropivacaine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 PainReform Ltd
2.2.1 PainReform Ltd Details
2.2.2 PainReform Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 PainReform Ltd SWOT Analysis
2.2.4 PainReform Ltd Product and Services
2.2.5 PainReform Ltd Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Taiwan Liposome Company
2.3.1 Taiwan Liposome Company Details
2.3.2 Taiwan Liposome Company Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Taiwan Liposome Company SWOT Analysis
2.3.4 Taiwan Liposome Company Product and Services
2.3.5 Taiwan Liposome Company Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aspen Pharmacare
2.4.1 Aspen Pharmacare Details
2.4.2 Aspen Pharmacare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aspen Pharmacare SWOT Analysis
2.4.4 Aspen Pharmacare Product and Services
2.4.5 Aspen Pharmacare Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Encore Therapeutics
2.5.1 Encore Therapeutics Details
2.5.2 Encore Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Encore Therapeutics SWOT Analysis
2.5.4 Encore Therapeutics Product and Services
2.5.5 Encore Therapeutics Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene SWOT Analysis
2.6.4 Celgene Product and Services
2.6.5 Celgene Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Yichang Renfu Pharmaceutical
2.7.1 Yichang Renfu Pharmaceutical Details
2.7.2 Yichang Renfu Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Yichang Renfu Pharmaceutical SWOT Analysis
2.7.4 Yichang Renfu Pharmaceutical Product and Services
2.7.5 Yichang Renfu Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Heron Therapeutics
2.8.1 Heron Therapeutics Details
2.8.2 Heron Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Heron Therapeutics SWOT Analysis
2.8.4 Heron Therapeutics Product and Services
2.8.5 Heron Therapeutics Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Nuvo Pharmaceuticals
2.9.1 Nuvo Pharmaceuticals Details
2.9.2 Nuvo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Nuvo Pharmaceuticals SWOT Analysis
2.9.4 Nuvo Pharmaceuticals Product and Services
2.9.5 Nuvo Pharmaceuticals Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Anhui Wellman Pharmaceutical
2.10.1 Anhui Wellman Pharmaceutical Details
2.10.2 Anhui Wellman Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Anhui Wellman Pharmaceutical SWOT Analysis
2.10.4 Anhui Wellman Pharmaceutical Product and Services
2.10.5 Anhui Wellman Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Chengdu Tiantaishan Pharmaceutical
2.11.1 Chengdu Tiantaishan Pharmaceutical Details
2.11.2 Chengdu Tiantaishan Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Chengdu Tiantaishan Pharmaceutical SWOT Analysis
2.11.4 Chengdu Tiantaishan Pharmaceutical Product and Services
2.11.5 Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Jiangsu Enhua Pharmaceutical
2.12.1 Jiangsu Enhua Pharmaceutical Details
2.12.2 Jiangsu Enhua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Jiangsu Enhua Pharmaceutical SWOT Analysis
2.12.4 Jiangsu Enhua Pharmaceutical Product and Services
2.12.5 Jiangsu Enhua Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Shandong New Era Pharmaceutical
2.13.1 Shandong New Era Pharmaceutical Details
2.13.2 Shandong New Era Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Shandong New Era Pharmaceutical SWOT Analysis
2.13.4 Shandong New Era Pharmaceutical Product and Services
2.13.5 Shandong New Era Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Zhejiang Xianju Pharmaceutical
2.14.1 Zhejiang Xianju Pharmaceutical Details
2.14.2 Zhejiang Xianju Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Zhejiang Xianju Pharmaceutical SWOT Analysis
2.14.4 Zhejiang Xianju Pharmaceutical Product and Services
2.14.5 Zhejiang Xianju Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Yangtze Pharmaceutical Group
2.15.1 Yangtze Pharmaceutical Group Details
2.15.2 Yangtze Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Yangtze Pharmaceutical Group SWOT Analysis
2.15.4 Yangtze Pharmaceutical Group Product and Services
2.15.5 Yangtze Pharmaceutical Group Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Guangdong Jiabo Pharmaceutical
2.16.1 Guangdong Jiabo Pharmaceutical Details
2.16.2 Guangdong Jiabo Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Guangdong Jiabo Pharmaceutical SWOT Analysis
2.16.4 Guangdong Jiabo Pharmaceutical Product and Services
2.16.5 Guangdong Jiabo Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Shanxi Pude Pharmaceutical
2.17.1 Shanxi Pude Pharmaceutical Details
2.17.2 Shanxi Pude Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Shanxi Pude Pharmaceutical SWOT Analysis
2.17.4 Shanxi Pude Pharmaceutical Product and Services
2.17.5 Shanxi Pude Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Hebei Yipin Pharmaceutical
2.18.1 Hebei Yipin Pharmaceutical Details
2.18.2 Hebei Yipin Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Hebei Yipin Pharmaceutical SWOT Analysis
2.18.4 Hebei Yipin Pharmaceutical Product and Services
2.18.5 Hebei Yipin Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Jiangsu Hengrui Pharmaceutical
2.19.1 Jiangsu Hengrui Pharmaceutical Details
2.19.2 Jiangsu Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Jiangsu Hengrui Pharmaceutical SWOT Analysis
2.19.4 Jiangsu Hengrui Pharmaceutical Product and Services
2.19.5 Jiangsu Hengrui Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Guangdong Huarun Shunfeng Pharmaceutical
2.20.1 Guangdong Huarun Shunfeng Pharmaceutical Details
2.20.2 Guangdong Huarun Shunfeng Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Guangdong Huarun Shunfeng Pharmaceutical SWOT Analysis
2.20.4 Guangdong Huarun Shunfeng Pharmaceutical Product and Services
2.20.5 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Hainan Sida Pharmaceutical
2.21.1 Hainan Sida Pharmaceutical Details
2.21.2 Hainan Sida Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Hainan Sida Pharmaceutical SWOT Analysis
2.21.4 Hainan Sida Pharmaceutical Product and Services
2.21.5 Hainan Sida Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Shenyang Sansheng Pharmaceutical
2.22.1 Shenyang Sansheng Pharmaceutical Details
2.22.2 Shenyang Sansheng Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Shenyang Sansheng Pharmaceutical SWOT Analysis
2.22.4 Shenyang Sansheng Pharmaceutical Product and Services
2.22.5 Shenyang Sansheng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Qilu Pharmaceutical
2.23.1 Qilu Pharmaceutical Details
2.23.2 Qilu Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Qilu Pharmaceutical SWOT Analysis
2.23.4 Qilu Pharmaceutical Product and Services
2.23.5 Qilu Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.24 Shaanxi Bosen Biopharmaceutical
2.24.1 Shaanxi Bosen Biopharmaceutical Details
2.24.2 Shaanxi Bosen Biopharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Shaanxi Bosen Biopharmaceutical SWOT Analysis
2.24.4 Shaanxi Bosen Biopharmaceutical Product and Services
2.24.5 Shaanxi Bosen Biopharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.25 Xi’an Hanfeng Pharmaceutical
2.25.1 Xi’an Hanfeng Pharmaceutical Details
2.25.2 Xi’an Hanfeng Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.25.3 Xi’an Hanfeng Pharmaceutical SWOT Analysis
2.25.4 Xi’an Hanfeng Pharmaceutical Product and Services
2.25.5 Xi’an Hanfeng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.26 Chenxin Pharmaceutical
2.26.1 Chenxin Pharmaceutical Details
2.26.2 Chenxin Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.26.3 Chenxin Pharmaceutical SWOT Analysis
2.26.4 Chenxin Pharmaceutical Product and Services
2.26.5 Chenxin Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ropivacaine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ropivacaine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ropivacaine Manufacturer Market Share in 2019
3.3.2 Top 6 Ropivacaine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ropivacaine Sales, Revenue and Market Share by Regions
4.1.1 Global Ropivacaine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ropivacaine Revenue and Market Share by Regions (2015-2020)
4.2 North America Ropivacaine Sales and Growth Rate (2015-2020)
4.3 Europe Ropivacaine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ropivacaine Sales and Growth Rate (2015-2020)
4.5 South America Ropivacaine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ropivacaine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ropivacaine Sales, Revenue and Market Share by Country
5.1.1 North America Ropivacaine Sales and Market Share by Country (2015-2020)
5.1.2 North America Ropivacaine Revenue and Market Share by Country (2015-2020)
5.2 United States Ropivacaine Sales and Growth Rate (2015-2020)
5.3 Canada Ropivacaine Sales and Growth Rate (2015-2020)
5.4 Mexico Ropivacaine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ropivacaine Sales, Revenue and Market Share by Country
6.1.1 Europe Ropivacaine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ropivacaine Revenue and Market Share by Country (2015-2020)
6.2 Germany Ropivacaine Sales and Growth Rate (2015-2020)
6.3 UK Ropivacaine Sales and Growth Rate (2015-2020)
6.4 France Ropivacaine Sales and Growth Rate (2015-2020)
6.5 Russia Ropivacaine Sales and Growth Rate (2015-2020)
6.6 Italy Ropivacaine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ropivacaine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ropivacaine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ropivacaine Revenue and Market Share by Regions (2015-2020)
7.2 China Ropivacaine Sales and Growth Rate (2015-2020)
7.3 Japan Ropivacaine Sales and Growth Rate (2015-2020)
7.4 Korea Ropivacaine Sales and Growth Rate (2015-2020)
7.5 India Ropivacaine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ropivacaine Sales and Growth Rate (2015-2020)
7.7 Australia Ropivacaine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ropivacaine Sales, Revenue and Market Share by Country
8.1.1 South America Ropivacaine Sales and Market Share by Country (2015-2020)
8.1.2 South America Ropivacaine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ropivacaine Sales and Growth Rate (2015-2020)
8.3 Argentina Ropivacaine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ropivacaine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ropivacaine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ropivacaine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ropivacaine Sales and Growth Rate (2015-2020)
9.3 Turkey Ropivacaine Sales and Growth Rate (2015-2020)
9.4 Egypt Ropivacaine Sales and Growth Rate (2015-2020)
9.5 South Africa Ropivacaine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ropivacaine Sales and Market Share by Type (2015-2020)
10.2 Global Ropivacaine Revenue and Market Share by Type (2015-2020)
10.3 Global Ropivacaine Price by Type (2015-2020)
11 Global Ropivacaine Market Segment by Application
11.1 Global Ropivacaine Sales Market Share by Application (2015-2020)
11.2 Global Ropivacaine Revenue Market Share by Application (2015-2020)
11.3 Global Ropivacaine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ropivacaine Sales, Revenue and Growth Rate (2021-2025)
12.2 Ropivacaine Market Forecast by Regions (2021-2025)
12.2.1 North America Ropivacaine Market Forecast (2021-2025)
12.2.2 Europe Ropivacaine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ropivacaine Market Forecast (2021-2025)
12.2.4 South America Ropivacaine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ropivacaine Market Forecast (2021-2025)
12.3 Ropivacaine Market Forecast by Type (2021-2025)
12.3.1 Global Ropivacaine Sales Forecast by Type (2021-2025)
12.3.2 Global Ropivacaine Market Share Forecast by Type (2021-2025)
12.4 Ropivacaine Market Forecast by Application (2021-2025)
12.4.1 Global Ropivacaine Sales Forecast by Application (2021-2025)
12.4.2 Global Ropivacaine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ropivacaine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ropivacaine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ropivacaine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Ropivacaine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Ropivacaine Major Business
Table 10. AstraZeneca Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 11. AstraZeneca SWOT Analysis
Table 12. AstraZeneca Ropivacaine Product and Services
Table 13. AstraZeneca Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. PainReform Ltd Basic Information, Manufacturing Base and Competitors
Table 15. PainReform Ltd Ropivacaine Major Business
Table 16. PainReform Ltd Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 17. PainReform Ltd SWOT Analysis
Table 18. PainReform Ltd Ropivacaine Product and Services
Table 19. PainReform Ltd Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Taiwan Liposome Company Basic Information, Manufacturing Base and Competitors
Table 21. Taiwan Liposome Company Ropivacaine Major Business
Table 22. Taiwan Liposome Company Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 23. Taiwan Liposome Company SWOT Analysis
Table 24. Taiwan Liposome Company Ropivacaine Product and Services
Table 25. Taiwan Liposome Company Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Aspen Pharmacare Basic Information, Manufacturing Base and Competitors
Table 27. Aspen Pharmacare Ropivacaine Major Business
Table 28. Aspen Pharmacare Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 29. Aspen Pharmacare SWOT Analysis
Table 30. Aspen Pharmacare Ropivacaine Product and Services
Table 31. Aspen Pharmacare Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Encore Therapeutics Basic Information, Manufacturing Base and Competitors
Table 33. Encore Therapeutics Ropivacaine Major Business
Table 34. Encore Therapeutics Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 35. Encore Therapeutics SWOT Analysis
Table 36. Encore Therapeutics Ropivacaine Product and Services
Table 37. Encore Therapeutics Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Celgene Basic Information, Manufacturing Base and Competitors
Table 39. Celgene Ropivacaine Major Business
Table 40. Celgene Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 41. Celgene SWOT Analysis
Table 42. Celgene Ropivacaine Product and Services
Table 43. Celgene Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Yichang Renfu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 45. Yichang Renfu Pharmaceutical Ropivacaine Major Business
Table 46. Yichang Renfu Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 47. Yichang Renfu Pharmaceutical SWOT Analysis
Table 48. Yichang Renfu Pharmaceutical Ropivacaine Product and Services
Table 49. Yichang Renfu Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 51. Heron Therapeutics Ropivacaine Major Business
Table 52. Heron Therapeutics Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 53. Heron Therapeutics SWOT Analysis
Table 54. Heron Therapeutics Ropivacaine Product and Services
Table 55. Heron Therapeutics Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Nuvo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 57. Nuvo Pharmaceuticals Ropivacaine Major Business
Table 58. Nuvo Pharmaceuticals Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 59. Nuvo Pharmaceuticals SWOT Analysis
Table 60. Nuvo Pharmaceuticals Ropivacaine Product and Services
Table 61. Nuvo Pharmaceuticals Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Anhui Wellman Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 63. Anhui Wellman Pharmaceutical Ropivacaine Major Business
Table 64. Anhui Wellman Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 65. Anhui Wellman Pharmaceutical SWOT Analysis
Table 66. Anhui Wellman Pharmaceutical Ropivacaine Product and Services
Table 67. Anhui Wellman Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Chengdu Tiantaishan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Chengdu Tiantaishan Pharmaceutical Ropivacaine Major Business
Table 70. Chengdu Tiantaishan Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 71. Chengdu Tiantaishan Pharmaceutical SWOT Analysis
Table 72. Chengdu Tiantaishan Pharmaceutical Ropivacaine Product and Services
Table 73. Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Jiangsu Enhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 75. Jiangsu Enhua Pharmaceutical Ropivacaine Major Business
Table 76. Jiangsu Enhua Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 77. Jiangsu Enhua Pharmaceutical SWOT Analysis
Table 78. Jiangsu Enhua Pharmaceutical Ropivacaine Product and Services
Table 79. Jiangsu Enhua Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. Shandong New Era Pharmaceutical Ropivacaine Major Business
Table 82. Shandong New Era Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 83. Shandong New Era Pharmaceutical SWOT Analysis
Table 84. Shandong New Era Pharmaceutical Ropivacaine Product and Services
Table 85. Shandong New Era Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 87. Zhejiang Xianju Pharmaceutical Ropivacaine Major Business
Table 88. Zhejiang Xianju Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 89. Zhejiang Xianju Pharmaceutical SWOT Analysis
Table 90. Zhejiang Xianju Pharmaceutical Ropivacaine Product and Services
Table 91. Zhejiang Xianju Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Yangtze Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 93. Yangtze Pharmaceutical Group Ropivacaine Major Business
Table 94. Yangtze Pharmaceutical Group Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 95. Yangtze Pharmaceutical Group SWOT Analysis
Table 96. Yangtze Pharmaceutical Group Ropivacaine Product and Services
Table 97. Yangtze Pharmaceutical Group Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Guangdong Jiabo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 99. Guangdong Jiabo Pharmaceutical Ropivacaine Major Business
Table 100. Guangdong Jiabo Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 101. Guangdong Jiabo Pharmaceutical SWOT Analysis
Table 102. Guangdong Jiabo Pharmaceutical Ropivacaine Product and Services
Table 103. Guangdong Jiabo Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Shanxi Pude Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 105. Shanxi Pude Pharmaceutical Ropivacaine Major Business
Table 106. Shanxi Pude Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 107. Shanxi Pude Pharmaceutical SWOT Analysis
Table 108. Shanxi Pude Pharmaceutical Ropivacaine Product and Services
Table 109. Shanxi Pude Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Hebei Yipin Pharmaceutical Ropivacaine Type and Application
Table 111. Hebei Yipin Pharmaceutical Ropivacaine Major Business
Table 112. Hebei Yipin Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 113. Hebei Yipin Pharmaceutical SWOT Analysis
Table 114. Hebei Yipin Pharmaceutical Ropivacaine Product and Services
Table 115. Hebei Yipin Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 117. Jiangsu Hengrui Pharmaceutical Ropivacaine Major Business
Table 118. Jiangsu Hengrui Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 119. Jiangsu Hengrui Pharmaceutical SWOT Analysis
Table 120. Jiangsu Hengrui Pharmaceutical Ropivacaine Product and Services
Table 121. Jiangsu Hengrui Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 122. Guangdong Huarun Shunfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 123. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Major Business
Table 124. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 125. Guangdong Huarun Shunfeng Pharmaceutical SWOT Analysis
Table 126. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Product and Services
Table 127. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 128. Hainan Sida Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 129. Hainan Sida Pharmaceutical Ropivacaine Major Business
Table 130. Hainan Sida Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 131. Hainan Sida Pharmaceutical SWOT Analysis
Table 132. Hainan Sida Pharmaceutical Ropivacaine Product and Services
Table 133. Hainan Sida Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 134. Shenyang Sansheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 135. Shenyang Sansheng Pharmaceutical Ropivacaine Major Business
Table 136. Shenyang Sansheng Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 137. Shenyang Sansheng Pharmaceutical SWOT Analysis
Table 138. Shenyang Sansheng Pharmaceutical Ropivacaine Product and Services
Table 139. Shenyang Sansheng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 140. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 141. Qilu Pharmaceutical Ropivacaine Major Business
Table 142. Qilu Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 143. Qilu Pharmaceutical SWOT Analysis
Table 144. Qilu Pharmaceutical Ropivacaine Product and Services
Table 145. Qilu Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 146. Shaanxi Bosen Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 147. Shaanxi Bosen Biopharmaceutical Ropivacaine Major Business
Table 148. Shaanxi Bosen Biopharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 149. Shaanxi Bosen Biopharmaceutical SWOT Analysis
Table 150. Shaanxi Bosen Biopharmaceutical Ropivacaine Product and Services
Table 151. Shaanxi Bosen Biopharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 152. Xi'an Hanfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 153. Xi'an Hanfeng Pharmaceutical Ropivacaine Major Business
Table 154. Xi'an Hanfeng Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 155. Xi'an Hanfeng Pharmaceutical SWOT Analysis
Table 156. Xi'an Hanfeng Pharmaceutical Ropivacaine Product and Services
Table 157. Xi'an Hanfeng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 158. Chenxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 159. Chenxin Pharmaceutical Ropivacaine Major Business
Table 160. Chenxin Pharmaceutical Ropivacaine Total Revenue (USD Million) (2018-2019)
Table 161. Chenxin Pharmaceutical SWOT Analysis
Table 162. Chenxin Pharmaceutical Ropivacaine Product and Services
Table 163. Chenxin Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 164. Global Ropivacaine Sales by Manufacturer (2018-2019) (K Doses)
Table 165. Global Ropivacaine Revenue by Manufacturer (2018-2019) (USD Million)
Table 166. Global Ropivacaine Sales by Regions (2015-2020) (K Doses)
Table 167. Global Ropivacaine Sales Market Share by Regions (2015-2020)
Table 168. Global Ropivacaine Revenue by Regions (2015-2020) (USD Million)
Table 169. North America Ropivacaine Sales by Countries (2015-2020) (K Doses)
Table 170. North America Ropivacaine Sales Market Share by Countries (2015-2020)
Table 171. North America Ropivacaine Revenue by Countries (2015-2020) (USD Million)
Table 172. North America Ropivacaine Revenue Market Share by Countries (2015-2020)
Table 173. Europe Ropivacaine Sales by Countries (2015-2020) (K Doses)
Table 174. Europe Ropivacaine Sales Market Share by Countries (2015-2020)
Table 175. Europe Ropivacaine Revenue by Countries (2015-2020) (USD Million)
Table 176. Asia-Pacific Ropivacaine Sales by Regions (2015-2020) (K Doses)
Table 177. Asia-Pacific Ropivacaine Sales Market Share by Regions (2015-2020)
Table 178. Asia-Pacific Ropivacaine Revenue by Regions (2015-2020) (USD Million)
Table 179. South America Ropivacaine Sales by Countries (2015-2020) (K Doses)
Table 180. South America Ropivacaine Sales Market Share by Countries (2015-2020)
Table 181. South America Ropivacaine Revenue by Countries (2015-2020) (USD Million)
Table 182. South America Ropivacaine Revenue Market Share by Countries (2015-2020)
Table 183. Middle East & Africa Ropivacaine Sales by Countries (2015-2020) (K Doses)
Table 184. Middle East & Africa Ropivacaine Sales Market Share by Countries (2015-2020)
Table 185. Middle East & Africa Ropivacaine Revenue by Countries (2015-2020) (USD Million)
Table 186. Middle East & Africa Ropivacaine Revenue Market Share by Countries (2015-2020)
Table 187. Global Ropivacaine Sales by Type (2015-2020) (K Doses)
Table 188. Global Ropivacaine Sales Share by Type (2015-2020)
Table 189. Global Ropivacaine Revenue by Type (2015-2020) (USD Million)
Table 190. Global Ropivacaine Revenue Share by Type (2015-2020)
Table 191. Global Ropivacaine Sales by Application (2015-2020) (K Doses)
Table 192. Global Ropivacaine Sales Share by Application (2015-2020)
Table 193. Global Ropivacaine Sales Forecast by Regions (2021-2025) (K Doses)
Table 194. Global Ropivacaine Market Share Forecast by Regions (2021-2025)
Table 195. Global Ropivacaine Sales Forecast by Type (2021-2025) (K Doses)
Table 196. Global Ropivacaine Market Share Forecast by Type (2021-2025)
Table 197. Global Ropivacaine Sales Forecast by Application (2021-2025)
Table 198. Global Ropivacaine Market Share Forecast by Application (2021-2025)
Table 199. Direct Channel Pros & Cons
Table 200. Indirect Channel Pros & Cons
Table 201. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ropivacaine Picture
Figure 2. Global Sales Market Share of Ropivacaine by Type in 2019
Figure 3. Lumbar Epidural Administration Picture
Figure 4. Thoracic Epidural Administration Picture
Figure 5. Regional Block Picture
Figure 6. Ropivacaine Sales Market Share by Application in 2018
Figure 7. Anesthesia Picture
Figure 8. Systemic Neuropathic Pain Picture
Figure 9. Postherpes Pain Picture
Figure 10. Post-Operative Pain Picture
Figure 11. Surgical Analgesia Picture
Figure 12. Labor Analgesia Picture
Figure 13. Other Picture
Figure 14. Global Ropivacaine Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Ropivacaine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Ropivacaine Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Ropivacaine Sales Market Share by Manufacturer in 2019
Figure 35. Global Ropivacaine Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Ropivacaine Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Ropivacaine Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 40. Global Ropivacaine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Ropivacaine Revenue Market Share by Regions (2015-2020)
Figure 42. Global Ropivacaine Revenue Market Share by Regions in 2018
Figure 43. North America Ropivacaine Sales and Growth Rate (2015-2020)
Figure 44. Europe Ropivacaine Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Ropivacaine Sales and Growth Rate (2015-2020)
Figure 46. South America Ropivacaine Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Ropivacaine Sales and Growth Rate (2015-2020)
Figure 48. North America Ropivacaine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Ropivacaine Sales Market Share by Countries (2015-2020)
Figure 50. North America Ropivacaine Sales Market Share by Countries in 2018
Figure 51. North America Ropivacaine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Ropivacaine Revenue Market Share by Countries in 2018
Figure 53. United States Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. Canada Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. Mexico Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Europe Ropivacaine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Ropivacaine Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Ropivacaine Revenue Market Share by Countries in 2019
Figure 59. Germany Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. UK Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. France Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Russia Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Italy Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Asia-Pacific Ropivacaine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Ropivacaine Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Ropivacaine Revenue Market Share by Regions 2019
Figure 67. China Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. Japan Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. Korea Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. India Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Southeast Asia Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. South America Ropivacaine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Ropivacaine Sales Market Share by Countries in 2019
Figure 74. South America Ropivacaine Revenue Market Share by Countries in 2019
Figure 75. Brazil Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Argentina Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Middle East and Africa Ropivacaine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Ropivacaine Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Ropivacaine Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Ropivacaine Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. Egypt Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 83. Turkey Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 84. South Africa Ropivacaine Sales and Growth Rate (2015-2020) (K Doses)
Figure 85. Global Ropivacaine Sales and Growth Rate (2021-2025) (K Doses)
Figure 86. Global Ropivacaine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Ropivacaine Market Forecast (2021-2025) (K Doses)
Figure 88. Europe Sales Ropivacaine Market Forecast (2021-2025) (K Doses)
Figure 89. Asia-Pacific Sales Ropivacaine Market Forecast (2021-2025) (K Doses)
Figure 90. South America Sales Ropivacaine Market Forecast (2021-2025) (K Doses)
Figure 91. Middle East & Africa Sales Ropivacaine Market Forecast (2021-2025) (K Doses)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
硬膜外カテーテルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Epidural Catheter market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Epidural Catheter market re…- 骨痛治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bone Pain Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bone Pain Treatment marke…
- 神経障害痛治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Neuropathy Pain Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pain Reliever market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pain Reliever market report pro…
- 局所鎮痛剤の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Topical Pain Relievers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…